爱美客：取得治疗男性型脱发用药米诺地尔搽剂药品注册证书

Core Viewpoint - Aimeike (300896.SZ) announced that its wholly-owned subsidiary, Beijing Nobot Biotechnology Co., Ltd., received the drug registration certificate for Minoxidil topical solution from the National Medical Products Administration [1] Group 1: Product Details - The Minoxidil topical solution is available in two specifications: 2% and 5% [1] - The 2% specification is indicated for the treatment of androgenetic alopecia and alopecia areata [1] - The 5% specification is restricted for use in males only, specifically for treating androgenetic alopecia and alopecia areata [1]